期刊
SCIENTIFIC REPORTS
卷 5, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/srep14041
关键词
-
资金
- JSPS, Strategic Research Program for Brain Sciences - Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [10036069]
- MEXT-Supported Programs for the Strategic Research Foundation at Private Universities
- Japan Diabetes Foundation
- Takeda Science Foundation
- Salt Science Research Foundation
- KEIRIN RACE
- Grants-in-Aid for Scientific Research [15K09397, 15K09396] Funding Source: KAKEN
Gastric hormone ghrelin regulates insulin secretion, as well as growth hormone release, feeding behavior and adiposity. Ghrelin is known to exert its biological actions by interacting with the growth hormone secretagogue-receptor (GHSR) coupled to G(q/11)-protein signaling. By contrast, ghrelin acts on pancreatic islet beta-cells via G(i)-protein-mediated signaling. These observations raise a question whether the ghrelin action on islet beta-cells involves atypical GHSR and/or distinct signal transduction. Furthermore, the role of the beta-cell GHSR in the systemic glycemic effect of ghrelin still remains to be defined. To address these issues, the present study employed the global GHSR-null mice and those re-expressing GHSR selectively in beta-cells. We here report that ghrelin attenuates glucose-induced insulin release via direct interaction with ordinary GHSR that is uniquely coupled to novel cAMP/TRPM2 signaling in beta-cells, and that this beta-cell GHSR with unique insulinostatic signaling largely accounts for the systemic effects of ghrelin on circulating glucose and insulin levels. The novel beta-cell specific GHSR-cAMP/TRPM2 signaling provides a potential therapeutic target for the treatment of type 2 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据